This is the protocol for a review and there is no abstract. The objectives are as follows:
The primary objective of this review is to evaluate the efficacy and safety of medical agents used for induction of MH in CD as it is frequently used as a major outcome in clinical trials.
If you can't find a tool you're looking for, please click the link at the top of the page to "Go to old article view". Alternatively, view our Knowledge Base articles for additional help. Your feedback is important to us, so please let us know if you have comments or ideas for improvement.